S 2554 · 115th Congress 2017–2019, ended

Patient Right to Know Drug Prices Act

Latest action · Oct 10, 2018 Became Public Law No: 115-263.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 14, 2018
  2. Passed SenateSep 17, 2018
  3. Passed HouseSep 25, 2018
  4. To the PresidentOct 1, 2018
  5. Became lawOct 10, 2018Public Law 115-263

Summary

Patient Right to Know Drug Prices Act

(Sec. 2) This bill amends the Public Health Service Act to prohibit a health insurance plan or pharmacy benefits manager from restricting a pharmacy from informing an enrollee of any difference between the out-of-pocket cost of a drug under the plan and the cost of the drug without health insurance coverage. (Such restrictions are commonly referred to as gag clauses.)

(Sec. 3) The bill also amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to apply certain antitrust filing requirements for generic drug applicants to biosimilar biological product applicants. (Biosimilar biological products, commonly referred to as biosimilars, are biological products approved by the Food and Drug Administration based on their similarity to an already-approved biological product.) Under current law, generic drug applicants that make agreements with brand name drug companies or other generic drug applicants regarding the manufacture, marketing, or sale of their drugs must file such agreements with the Federal Trade Commission and the Department of Justice. The bill subjects biosimilar biological product applicants to the same filing requirements.

Recorded votes 1

Newest first. Open one to see how every member voted.

Roll callQuestionResultDate
Senate 209On Passage of the Bill S. 2554Bill Passed98–2Sep 17, 2018

Yea 98

Nay 2

Cosponsors 25

Members who signed on, in the order they did. Signatures ran from Mar 14, 2018 to Sep 17, 2018; 4 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-LABill CassidyOriginalMar 14, 2018
D-MOClaire McCaskillOriginalMar 14, 2018
D-MIDebbie StabenowOriginalMar 14, 2018
R-WYJohn BarrassoOriginalMar 14, 2018
D-MNTina SmithJun 7, 2018
D-INJoe DonnellyJun 11, 2018
D-CADianne FeinsteinJul 9, 2018
R-AKLisa MurkowskiJul 19, 2018
D-NJRobert MenendezJul 19, 2018
D-WITammy BaldwinJul 24, 2018
R-LAJohn KennedyJul 25, 2018
D-NHMargaret Wood HassanJul 25, 2018
D-CTRichard BlumenthalJul 30, 2018
D-NDHeidi HeitkampAug 1, 2018
R-MSRoger F. WickerAug 1, 2018

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred Mar 14, 2018Markup Jul 25, 2018Reported Jul 31, 2018

Actions 18

Everything that happened, newest first.

  1. Oct 10, 2018Signed by President.
  2. Oct 10, 2018Became Public Law No: 115-263.
  3. Oct 1, 2018Presented to President.
  4. Sep 25, 2018Mr. Carter (GA) moved to suspend the rules and pass the bill.
  5. Sep 25, 2018Considered under suspension of the rules. (consideration: CR H8795-8799)

In the Congressional Record 5

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S7221Chuck Grassley R-IANov 29, 2018
HouseDebate and remarks H8795–H8799Text printed H8795Earl L. "Buddy" Carter R-GA, Frank Pallone, Jr. D-NJ, Greg Walden R-OR, John P. Sarbanes D-MD, Lloyd Doggett D-TXSep 25, 2018
SenateDebate and remarks S6164, S6170–S6173, S6175, S6176, S6178Amendments S6179Recorded votes S6179, S6180enactLee amendment (ensure self-insured group health insurance plans that are exempt from State regulations do not prohibit pharmacy providers from providing certain information to enrollees)Bill Cassidy R-LA, Claire McCaskill D-MO, Dianne Feinstein D-CA, John Barrasso R-WY, Lamar Alexander R-TN, Mike Lee R-UT (amendment), Mitch McConnell R-KY, Susan M. Collins R-MESep 17, 2018
SenateDebate and remarks S6105Amendments S6062Mike Lee R-UT (amendment), Mitch McConnell R-KYSep 6, 2018
SenateDebate and remarks S2664–S2667Joe Donnelly D-IN, Susan M. Collins R-MEMay 15, 2018

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Congressional Budget Office cost estimate

  1. Sep 12, 2018S. 2554, Patient Right to Know Drug Prices ActAs reported by the Senate Committee on Health, Education, Labor, and Pensions on July 31, 2018

CRS reports 6

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 6

Products on other subjects that cite it, usually among other measures.

Amendments 1

Amendments offered to this bill.

AmendmentDescriptionOffered byStatus
SA 4011To limit application of the gag clause to self-insured group health plans.Mike Lee R-UTAmendment SA 4011 not agreed to in Senate by Yea-Nay Vote. 11 - 89. Record Vote Number: 208.

Related bills 3

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 2553Know the Lowest Price Act of 2018Related billOct 10, 2018
HR 6143Patient Right to Know Drug Prices ActIdentical billJun 19, 2018
HR 6733Know the Cost Act of 2018Related billSep 13, 2018

Titles 8

Every title it has carried, official and short, at each stage.

Official Title
An act to ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees
Short Title
Patient Right to Know Drug Prices Act
Official Title as Introduced
A bill to ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees.
Short Titles as Introduced
Patient Right to Know Drug Prices Act
Short Titles as Reported to Senate
Patient Right to Know Drug Prices Act
Short Titles as Passed House
Patient Right to Know Drug Prices Act
Short Titles as Passed Senate
Patient Right to Know Drug Prices Act
Short Titles as Enacted
Patient Right to Know Drug Prices Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 4

Each version as it was printed, newest first.

  1. —Enrolled Bill
  2. Sep 17, 2018Engrossed in Senate
  3. Jul 31, 2018Reported to Senate
  4. Mar 14, 2018Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.